Literature DB >> 9609818

Overlapping functions of the myogenic bHLH genes MRF4 and MyoD revealed in double mutant mice.

A Rawls1, M R Valdez, W Zhang, J Richardson, W H Klein, E N Olson.   

Abstract

The myogenic basic helix-loop-helix (bHLH) genes - MyoD, Myf5, myogenin and MRF4 - exhibit distinct, but overlapping expression patterns during development of the skeletal muscle lineage and loss-of-function mutations in these genes result in different effects on muscle development. MyoD and Myf5 have been shown to act early in the myogenic lineage to establish myoblast identity, whereas myogenin acts later to control myoblast differentiation. In mice lacking myogenin, there is a severe deficiency of skeletal muscle, but some residual muscle fibers are present in mutant mice at birth. Mice lacking MRF4 are viable and have skeletal muscle, but they upregulate myogenin expression, which could potentially compensate for the absence of MRF4. Previous studies in which Myf5 and MRF4 null mutations were combined suggested that these genes do not share overlapping myogenic functions in vivo. To determine whether the functions of MRF4 might overlap with those of myogenin or MyoD, we generated double mutant mice lacking MRF4 and either myogenin or MyoD. MRF4/myogenin double mutant mice contained a comparable number of residual muscle fibers to mice lacking myogenin alone and myoblasts from those double mutant mice formed differentiated multinucleated myotubes in vitro as efficiently as wild-type myoblasts, indicating that neither myogenin nor MRF4 is absolutely essential for myoblast differentiation. Whereas mice lacking either MRF4 or MyoD were viable and did not show defects in muscle development, MRF4/MyoD double mutants displayed a severe muscle deficiency similar to that in myogenin mutants. Myogenin was expressed in MRF4/MyoD double mutants, indicating that myogenin is insufficient to support normal myogenesis in vivo. These results reveal unanticipated compensatory roles for MRF4 and MyoD in the muscle differentiation pathway and suggest that a threshold level of myogenic bHLH factors is required to activate muscle structural genes, with this level normally being achieved by combinations of multiple myogenic bHLH factors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9609818     DOI: 10.1242/dev.125.13.2349

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  45 in total

1.  Molecular distinction between specification and differentiation in the myogenic basic helix-loop-helix transcription factor family.

Authors:  D A Bergstrom; S J Tapscott
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

2.  The expression of the myogenic regulatory factors in denervated and normal muscles of different phenotypes.

Authors:  E H Walters; N C Stickland; P T Loughna
Journal:  J Muscle Res Cell Motil       Date:  2000       Impact factor: 2.698

3.  EKLF and KLF2 have compensatory roles in embryonic beta-globin gene expression and primitive erythropoiesis.

Authors:  Priyadarshi Basu; Tina K Lung; Wafaa Lemsaddek; Thanh Giang Sargent; David C Williams; Mohua Basu; Latasha C Redmond; Jerry B Lingrel; Jack L Haar; Joyce A Lloyd
Journal:  Blood       Date:  2007-08-03       Impact factor: 22.113

4.  A selective role for MRF4 in innervated adult skeletal muscle: Na(V) 1.4 Na+ channel expression is reduced in MRF4-null mice.

Authors:  Amy L Thompson; Gregory Filatov; Connie Chen; Isaac Porter; Yingjie Li; Mark M Rich; Susan D Kraner
Journal:  Gene Expr       Date:  2005

5.  Differential requirements for myogenic regulatory factors distinguish medial and lateral somitic, cranial and fin muscle fibre populations.

Authors:  Yaniv Hinits; Daniel P S Osborn; Simon M Hughes
Journal:  Development       Date:  2009-02       Impact factor: 6.868

6.  MRF4 protein expression in regenerating rat muscle.

Authors:  Z Zhou; A Bornemann
Journal:  J Muscle Res Cell Motil       Date:  2001       Impact factor: 2.698

7.  MyoR: a muscle-restricted basic helix-loop-helix transcription factor that antagonizes the actions of MyoD.

Authors:  J Lu; R Webb; J A Richardson; E N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

8.  Skeletal myogenesis and Myf5 activation.

Authors:  Tanja Francetic; Qiao Li
Journal:  Transcription       Date:  2011-05

Review 9.  Transcriptional networks controlling stromal cell differentiation.

Authors:  Alexander Rauch; Susanne Mandrup
Journal:  Nat Rev Mol Cell Biol       Date:  2021-04-09       Impact factor: 94.444

10.  Over-expression of the transcription factor, ZBP-89, leads to enhancement of the C2C12 myogenic program.

Authors:  Morgan Salmon; Gary K Owens; Zendra E Zehner
Journal:  Biochim Biophys Acta       Date:  2009-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.